Prostate Study: Reduced treatment time keeps moving organ in target field.
When we installed RapidArc, the 56-year-old prostate cancer patient was switched to from conventional IMRT radiotherapy to this more advanced method of treatment. The same dose was delivered to the prostate as with IMRT treatments, but the dose to such surrounding organs as the bladder and rectum was equal to or lower than that with IMRT. On each day of treatment with RapidArc, there was a... READ MORE